A Message From Professor Rudy Nuijts Friday May 22, 2020

A Message From Professor Rudy Nuijts  Friday May 22, 2020
Rudy Nuijts
Rudy Nuijts
Published: Friday, May 22, 2020
Dear Colleagues, As I write today in mid-May 2020, our governments are struggling to guide us on how to safely resume our personal and professional lives. Across Europe clinics closed to elective surgeries for two months are making careful plans to open, while ensuring measures are in place to keep themselves, their staff and their patients free from getting and spreading this virus. This is a daunting task we face and there will surely be successes and failures along the way. Our colleagues in Italy, Slovenia and the UK share with us their plans for making clinics safe and strategies for dealing with the backlog of patients awaiting surgery. And our colleague Alvin Young in Hong Kong charts for us his experience of COVID-19. Dr Sethuramam, in a JAMA viewpoint article, gives us an overview on testing for COVID-19 but, more optimistically, scientists at Imperial College London tell us they are trialling a test which could provide results in a little over a minute. If this test were successful and widely available, it would be transformative in managing our clinics in the time before a vaccine is available. Stay safe and well  
Rudy Nuijts Prof. dr Rudy MMA Nuijts ESCRS President
 
Tags: covid 19 rudy nuijts
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...